Background Growing evidence has suggested that immune-related genes play crucial roles
in the development and progression of hepatocellular carcinoma (HCC). Nevertheless, the …

Background Given poor prognosis and the lack of efficient therapy for advanced
hepatocellular carcinoma, immunotherapy has emerged as an increasingly important role …

Background Hepatocellular carcinoma (HCC) is one of the most prevalent and inflammation-
associated cancers. The tumor microenvironment (TME) plays an essential role in HCC …

Objective Hepatocellular carcinoma (HCC) has become the second most common tumor
type that contributes to cancer‐related death worldwide. The study aimed to establish a …

Immunity plays an important role in tumor development. In this study, we aimed to
investigate molecular classification and its prognostic value in hepatocellular carcinoma …

Background Hepatocellular carcinoma (HCC) is a highly heterogeneous disease, which
makes the prognostic prediction challenging. As part of the active cross-talk between the …

Background Hepatocellular carcinoma (HCC) ranks the fourth in terms of cancer-related
mortality globally. Herein, in this research, we attempted to develop a novel immune-related …

Immune‐related genes (IRGs) have been identified as critical drivers of the initiation and
progression of hepatocellular carcinoma (HCC). This study is aimed at constructing an IRG …

Abstract Changes in immune responses to hepatocellular carcinoma (HCC) are closely
related to the occurrence, development, and prognosis of this disease. Exploring the role of …

Background Although the tumour immune microenvironment is known to significantly
influence immunotherapy outcomes, its association with changes in gene expression …